Loading candles…
Bharat Parenterals Ltd is a third-generation family-owned pharmaceutical company incorporated in 1992. It manufactures and markets generic and specialty pharmaceutical formulations, with a focus on high-growth segments such as sterile injectables, tablets, and capsules. The company serves both domestic tender-based supplies within India and various international markets. Over more than 32 years of operations, Bharat Parenterals Ltd has developed its presence primarily in the pharmaceutical industry, engaging in the production and distribution of formulations across multiple geographies.
This page is a live market overview for BHARAT PARENTERALS LTD. (BPLPHARMA) on the NSE. As a listed security, BHARAT PARENTERALS LTD. is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for BPLPHARMA before placing trades on tick2trade.
As of the latest feed, BPLPHARMA last traded at ₹1,274 on NSE, down ₹0.3 (0.02%) from the previous close of ₹1,274.3. Today's session range is ₹0 – ₹0, against a 52-week band of ₹0 – ₹1,619. Traded volume today stands at — shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for BPLPHARMA in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether BPLPHARMA is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for BHARAT PARENTERALS LTD. before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in BPLPHARMA. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated BPLPHARMA option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Index Review | NSE indices rebalancing | 31 Mar 2026 |
| Expiry | Monthly F&O expiry | 30 Jan 2026 |
| Expiry | Monthly F&O expiry | 27 Feb 2026 |
| Holiday | Republic Day — market closed | 26 Jan 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.